Black Diamond Therapeutics, Inc. (BDTX)

HEALTH CARE: PHARMACEUTICALS
SIC: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)

ONE MAIN STREET, 10TH FLOOR CAMBRIDGE, MA 02142

Black Diamond Therapeutics, Inc. operates as a biotechnology company. The Company develops medicines for patients with genetically-defined cancers. Black Diamond Therapeutics serves customers in the United States.

Data as of 2021-05-08 12:06:43 -0400
Market Cap921.51 Million Shares Outstanding36.138 Million Avg 30-day Volume314.221 Thousand
P/E Ratio Dividend Yield EPS
Price/Sales Debt to Equity EBITDA
Price to Book Value0.0 Forward PE-9.33 Enterprise Value
Total Cash Current Debt Gross Profit
BETA1.0807 52-week High/Low46.25 / 21.04 Next Earnings Date2021-08-10 Price to Cash FLow (P/CF) -9999999.0
Data provided by IEX Cloud
View SEC Filings from BDTX instead.
Q4 2020 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 0 1 -100.0% 0 (0.0%) 0 (0.0%)
Funds Holding: 109 87 25.29% 36 (2.16%) 29 (1.8%) 24.14%
13F shares: 28.573 Million 23.663 Million 20.75% 9.27 Million 7.685 Million 20.63%
% Ownership 79.3787 65.7388 20.75% 25.7536 21.3498 20.63%
New Positions: 34 18 88.89% 12 8 50.0%
Increased Positions 43 38 13.16% 12 10 20.0%
Closed Positions 12 11 9.09% 5 6 -16.67%
Reduced Positions 11 18 -38.89% 4 7 -42.86%
Total Calls
Total Puts
PUT/CALL Ratio
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding BDTX (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding BDTX BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

13.2 Thousand total shares from 4 transactions

Exercise Derivative Conversion (M)

13.2 Thousand total shares from 4 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

ROBERTS CHRISTOPHER D. CHIEF SCIENTIFIC OFFICER

  • Officer
166,809 2021-05-03 12

MENZEL GARRY E

  • Director
14,921 2021-04-20 1

KULKARNI SAMARTH

  • Director
14,921 2021-04-20 1

HATZIS-SCHOCH BRENT SEE REMARKS

  • Officer
172,952 2021-04-12 10

SHAH RAJEEV M.

  • Director
2,590,347 2021-04-01 2

BEHBAHANI ALI

  • Director
3,449,304 2021-03-18 1

INGRAM ROBERT ALEXANDER

  • Director
6,182 2021-03-18 5

EPSTEIN DAVID M. SEE REMARKS

  • Officer
  • Director
0 2021-02-17 6

LEGGETT THOMAS CHIEF FINANCIAL OFFICER

  • Officer
0 2021-02-17 6

HUMPHREY RACHEL CHIEF MEDICAL OFFICER

  • Officer
0 2021-02-17 3

DHINGRA KAPIL

  • Director
10,000 2021-01-19 2

BOLZON BRADLEY J PHD

  • Director
  • 10% Owner
6,450,415 2020-12-14 20

VERSANT VENTURE CAPITAL VI, L.P.

VERSANT VOYAGEURS I PARALLEL, L.P.

VERSANT VOYAGEURS I, L.P.

VERSANT VANTAGE I, L.P.

  • 10% Owner
6,428,564 2020-12-14 14

FLYNN JAMES E

DEERFIELD MGMT L.P.

DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)

DEERFIELD PARTNERS, L.P.

  • 10% Owner
  • POSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUP
778,790 2020-02-03 0

WELLINGTON BIOMEDICAL INNOVATION MASTER INVESTORS (CAYMAN) I L.P.

  • 10% Owner
568,185 2020-02-03 0

MOTT DAVID M

  • 10% Owner
0 2020-01-29 0

MAKOWER JOSHUA

  • 10% Owner
0 2020-01-29 0

SANDELL SCOTT D

  • 10% Owner
0 2020-01-29 0

BASKETT FOREST

  • 10% Owner
0 2020-01-29 0

WALKER PAUL EDWARD

  • 10% Owner
0 2020-01-29 0

SONSINI PETER W.

  • 10% Owner
0 2020-01-29 0

FLORENCE ANTHONY A. JR.

  • 10% Owner
0 2020-01-29 0

MAKHZOUMI MOHAMAD

  • 10% Owner
0 2020-01-29 0

NEW ENTERPRISE ASSOCIATES 16, L.P.

NEA PARTNERS 16, L.P.

NEA 16 GP, LLC

  • 10% Owner
0 2020-01-29 0

MAYWEG ALEXANDER

  • Director
16,247 2020-01-29 0

CHANG CARMEN

  • 10% Owner
0 2020-01-29 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

ROBERTS CHRISTOPHER D. - Officer CHIEF SCIENTIFIC OFFICER

2021-05-05 16:31:37 -0400 2021-05-03 M 2,500 d 163,609 direct

ROBERTS CHRISTOPHER D. - Officer CHIEF SCIENTIFIC OFFICER

2021-05-05 16:31:37 -0400 2021-05-03 S 2,500 $26.64 d 3,200 direct yes -0.1957 0.0 1 -0.1957 2

ROBERTS CHRISTOPHER D. - Officer CHIEF SCIENTIFIC OFFICER

2021-05-05 16:31:37 -0400 2021-05-03 M 2,500 $10.86 a 5,700 direct -0.1957 0.0 1 -0.1957 2

KULKARNI SAMARTH - Director

2021-04-23 21:14:14 -0400 2021-04-20 A 14,921 a 14,921 direct

MENZEL GARRY E - Director

2021-04-23 21:14:47 -0400 2021-04-20 A 14,921 a 14,921 direct

HATZIS-SCHOCH BRENT - Officer SEE REMARKS

2021-04-13 20:45:24 -0400 2021-04-12 S 4,078 $25.00 d 8,400 direct yes 1.5707 5.1551 5.1551 6 -2.6983 4

HATZIS-SCHOCH BRENT - Officer SEE REMARKS

2021-04-13 20:45:24 -0400 2021-04-12 M 4,078 $3.20 a 12,478 direct 1.5707 5.1551 5.1551 6 -2.6983 4

HATZIS-SCHOCH BRENT - Officer SEE REMARKS

2021-04-13 20:45:24 -0400 2021-04-12 M 179,915 d 164,552 direct

ROBERTS CHRISTOPHER D. - Officer CHIEF SCIENTIFIC OFFICER

2021-04-07 17:17:22 -0400 2021-04-05 S 2,500 $25.54 d 3,200 direct yes -0.8454 1.5298 2.657 4 -0.8454 2

ROBERTS CHRISTOPHER D. - Officer CHIEF SCIENTIFIC OFFICER

2021-04-07 17:17:22 -0400 2021-04-05 M 2,500 $10.86 a 5,700 direct -0.8454 1.5298 2.657 4 -0.8454 2

ROBERTS CHRISTOPHER D. - Officer CHIEF SCIENTIFIC OFFICER

2021-04-07 17:17:22 -0400 2021-04-05 M 2,500 d 166,109 direct

SHAH RAJEEV M. - Director see footnote

2021-04-05 16:34:32 -0400 2021-04-01 J 353,814 $24.26 a 2,277,978 indirect -0.4105 4.6798 4.6798 6 -0.4105 2

BEHBAHANI ALI - Director

2021-03-22 20:33:00 -0400 2021-03-18 A 547 $24.01 a 547 direct -5.6794 -5.0484 4.0808 18.5107 25 -6.4788 5

SHAH RAJEEV M. - Director

2021-03-22 20:25:55 -0400 2021-03-18 A 443 $24.01 a 443 direct -5.6794 -5.0484 4.0808 18.5107 25 -6.4788 5

INGRAM ROBERT ALEXANDER - Director

2021-03-22 20:19:16 -0400 2021-03-18 A 677 $24.01 a 6,182 direct -5.6794 -5.0484 4.0808 18.5107 25 -6.4788 5

HATZIS-SCHOCH BRENT - Officer SEE REMARKS

2021-03-16 16:56:26 -0400 2021-03-12 M 4,078 $3.20 a 12,478 direct -7.118 -13.2689 5.5706 8.9749 29 -14.0039 9

HATZIS-SCHOCH BRENT - Officer SEE REMARKS

2021-03-16 16:56:26 -0400 2021-03-12 M 4,078 d 168,630 direct

HATZIS-SCHOCH BRENT - Officer SEE REMARKS

2021-03-16 16:56:26 -0400 2021-03-12 S 4,078 $26.36 d 8,400 direct yes -7.118 -13.2689 5.5706 8.9749 29 -14.0039 9

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
BLACK DIAMOND THERAPEUTICS I BDTX 2021-05-10 22:15:04 UTC -0.7182 0.7682 55000
BLACK DIAMOND THERAPEUTICS I BDTX 2021-05-10 21:45:02 UTC -0.7182 0.7682 55000
BLACK DIAMOND THERAPEUTICS I BDTX 2021-05-10 21:15:02 UTC -0.7182 0.7682 55000
BLACK DIAMOND THERAPEUTICS I BDTX 2021-05-10 20:45:03 UTC -0.7201 0.7701 55000
BLACK DIAMOND THERAPEUTICS I BDTX 2021-05-10 20:15:03 UTC -0.7201 0.7701 55000
BLACK DIAMOND THERAPEUTICS I BDTX 2021-05-10 19:45:03 UTC -0.7201 0.7701 55000
BLACK DIAMOND THERAPEUTICS I BDTX 2021-05-10 19:15:03 UTC -0.7201 0.7701 55000
BLACK DIAMOND THERAPEUTICS I BDTX 2021-05-10 18:45:03 UTC -0.7201 0.7701 55000
BLACK DIAMOND THERAPEUTICS I BDTX 2021-05-10 18:15:03 UTC -0.7201 0.7701 55000
BLACK DIAMOND THERAPEUTICS I BDTX 2021-05-10 17:45:02 UTC -0.7201 0.7701 55000
BLACK DIAMOND THERAPEUTICS I BDTX 2021-05-10 17:15:03 UTC -0.7201 0.7701 55000
BLACK DIAMOND THERAPEUTICS I BDTX 2021-05-10 16:45:03 UTC -0.7201 0.7701 55000
BLACK DIAMOND THERAPEUTICS I BDTX 2021-05-10 16:15:03 UTC -0.7201 0.7701 55000
BLACK DIAMOND THERAPEUTICS I BDTX 2021-05-10 15:45:03 UTC -0.7201 0.7701 55000
BLACK DIAMOND THERAPEUTICS I BDTX 2021-05-10 15:15:03 UTC -0.7201 0.7701 55000
BLACK DIAMOND THERAPEUTICS I BDTX 2021-05-10 14:45:04 UTC -0.738 0.788 55000
BLACK DIAMOND THERAPEUTICS I BDTX 2021-05-10 14:15:04 UTC -0.738 0.788 55000
BLACK DIAMOND THERAPEUTICS I BDTX 2021-05-10 13:45:04 UTC -0.738 0.788 55000
BLACK DIAMOND THERAPEUTICS I BDTX 2021-05-10 13:15:03 UTC -0.738 0.788 55000
BLACK DIAMOND THERAPEUTICS I BDTX 2021-05-10 12:45:02 UTC -0.738 0.788 55000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments